Novel immunotherapy may beat brain cancer

London, March 3 (IANS) Researchers, including one of Indian-origin, have shown that a next-generation cell-based immunotherapy may offer new hope in the fight against the most aggressive form of brain cancer called glioma.

Despite improvements in surgical procedures, chemotherapy, and radiotherapy, this type of brain tumour is still notoriously hard to treat — less than 10 percent of patients survive beyond five years.

Cell-based immunotherapy involves the injection of a therapeutic anticancer vaccine that stimulates the patient’s immune system to attack the tumour.

Thus far, the results of this type of immunotherapy have been mildly promising. However, Abhishek Garg and colleagues from the KU University of Leuven (KU Leuven) in Belgium have now found a novel way to produce more effective cell-based anticancer vaccines.

The researchers induced a specific type of cell death in brain cancer cells from mice. The dying cancer cells were then incubated together with dendritic cells, which play a vital role in the immune system.

The researchers discovered that this type of cancer cell killing releases ‘danger signals’ that fully activate the dendritic cells.

“We re-injected the activated dendritic cells into the mice as a therapeutic vaccine,” one of the researchers Patrizia Agostinis, professor at KU Leuven, explained.

“That vaccine alerted the immune system to the presence of dangerous cancer cells in the body. As a result, the immune system could recognize them and start attacking the brain tumour,” Agostinis noted.

Combined with chemotherapy, this novel cell-based immunotherapy drastically increased the survival rates of mice afflicted with brain tumours.

Almost 50 percent of the mice were completely cured. For the sake of comparison: none of the mice treated with chemotherapy alone became long-term survivors.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here